Status:
UNKNOWN
Comparison of Solid Organ Transplant
Lead Sponsor:
Methodist Health System
Conditions:
Gram-Negative Bacterial Infections
Gram-negative Bacteremia
Eligibility:
All Genders
18+ years
Brief Summary
Solid organ transplant (SOT) recipients have increased incidence of infections with MDRO pathogens. This difference leads to a disparity in antibiograms between SOT recipients and other hospitalized p...
Detailed Description
There is limited guidance for empiric antimicrobial therapy in this population. Local epidemiology plays a voluble role in managing infections empirically within the hospital setting. Antibiograms can...
Eligibility Criteria
Inclusion
- 18 years or older
Exclusion
- Missing data necessary to determine study outcomes
Key Trial Info
Start Date :
May 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04055922
Start Date
May 3 2018
End Date
May 1 2021
Last Update
January 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Methodist Dallas Medical Center
Dallas, Texas, United States, 75203